Fusion of OTT to BSAC Results in Aberrant Up-regulation of Transcriptional ActivityS

OTT/RBM15 - BSAC / MAL / MKL1/MRTF-A was identified as a fusion transcript generated by t(1;22)(p13;q13) in acute megakaryoblastic leukemia. Previous studies have shown that BSAC (basic, SAP, and coiled-coil domain) activates the promoters containing CArG boxes via interaction with serum response fa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2008-09, Vol.283 (39), p.26820-26828
Hauptverfasser: Sawada, Taisuke, Nishiyama, Chiharu, Kishi, Takuma, Sasazuki, Tomonari, Komazawa-Sakon, Sachiko, Xue, Xin, Piao, Jiang-Hu, Ogata, Hideko, Nakayama, Jun-ichi, Taki, Tomohiko, Hayashi, Yasuhide, Watanabe, Mamoru, Yagita, Hideo, Okumura, Ko, Nakano, Hiroyasu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:OTT/RBM15 - BSAC / MAL / MKL1/MRTF-A was identified as a fusion transcript generated by t(1;22)(p13;q13) in acute megakaryoblastic leukemia. Previous studies have shown that BSAC (basic, SAP, and coiled-coil domain) activates the promoters containing CArG boxes via interaction with serum response factor, and OTT (one twenty-two) negatively regulates the development of megakaryocytes and myeloid cells. However, the mechanism by which OTT-BSAC promotes leukemia is largely unknown. Here we show that OTT-BSAC, but not BSAC or OTT strongly activates several promoters containing a transcription factor Yin Yang 1-binding sequence. In addition, although BSAC predominantly localizes in the cytoplasm and its nuclear translocation is considered to be regulated by the Rho-actin signaling pathway, OTT-BSAC exclusively localizes in the nucleus. Moreover, OTT interacts with histone deacetylase 3, but this interaction is abolished in OTT-BSAC. Collectively, these functional and spatial changes of OTT and BSAC caused by the fusion might perturb their functions, culminating in the development of acute megakaryoblastic leukemia.
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M802315200